Format

Send to

Choose Destination
Bratisl Lek Listy. 2009;110(10):650-4.

Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.

Author information

1
Ondokuz Mayis University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Samsun, Turkey.

Abstract

OBJECTIVES:

To determine the predictive value for radiological damage of anti-cyclic citrullinated peptide antibodies (anti-CCP) and rheumatoid factor (RF) in patients with rheumatoid arthritis (RA).

METHODS:

Ninety patients with RA were enrolled in this study. All patients had symptom duration of at least one year. Anti-CCP and IgM-RF were evaluated with enzyme linked immunosorbent assay and nephelometry methods, respectively. Radiological damage was assessed by Larsen score.

RESULTS:

In forward stepwise logistic regression analysis, anti-CCP positivity and RF positivity were seen as significant independent predictors of the radiological outcomes (p = 0.01, p < 0.05, respectively). The combination of these antibodies had the highest risk for erosive joint damage (odds ratio = 25.71; 95% confidence interval, 4.7 to 140.13; p = 0.001).

CONCLUSION:

Our results suggest that the combined use of RF and anti-CCP has greater predictive value for erosive RA than anti-CCP or RF alone, and may facilitate to make a decision about the individual treatment in RA (Tab. 4, Ref. 37). Full Text (Free, PDF) www.bmj.sk.

PMID:
20017459
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center